XBiotech Inc (XBIT) — Cash Flow-to-Debt Ratio

Latest as of December 2025: -2.36x

XBiotech Inc (XBIT) has a Cash Flow-to-Debt Ratio of -2.36x as of December 2025, meaning its operating cash flow of $-22.95 Million could theoretically repay -2% of its total liabilities ($9.73 Million) in one year. Check XBIT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

CF-to-Debt Ratio

-2.36x
Operating CF / Total Liabilities

Operating Cash Flow

$-22.95 Million
USD

Total Liabilities

$9.73 Million
USD

Data as of

Dec 2025
Most recent filing

XBiotech Inc Cash Flow-to-Debt Ratio (2012–2025)

Historical debt coverage capacity for XBiotech Inc across 14 annual periods. Also explore XBIT total asset value for the complete picture of this company's asset base.

Annual Cash Flow-to-Debt Ratio for XBiotech Inc (2012–2025)

Year-by-year debt coverage analysis for XBiotech Inc. For market capitalisation and broader financial context, see XBIT company net worth.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 -4.10x $-39.92 Million $9.73 Million ▼ -122.9%
2024 -1.84x $-30.96 Million $16.82 Million ▲ +23.6%
2023 -2.41x $-18.73 Million $7.77 Million ▲ +7.3%
2022 -2.60x $-14.82 Million $5.70 Million ▼ -121.7%
2021 11.99x $69.44 Million $5.79 Million ▲ +194.0%
2020 -12.76x $-65.15 Million $5.11 Million ▼ -4178.1%
2019 -0.30x $-18.27 Million $61.25 Million ▲ +94.7%
2018 -5.61x $-16.54 Million $2.95 Million ▲ +53.1%
2017 -11.97x $-33.65 Million $2.81 Million ▼ -107.8%
2016 -5.76x $-46.02 Million $7.99 Million ▼ -9.1%
2015 -5.28x $-33.31 Million $6.31 Million ▼ -42.0%
2014 -3.72x $-11.70 Million $3.15 Million ▲ +64.7%
2013 -10.54x $-8.91 Million $845.00K ▲ +0.6%
2012 -10.61x $-11.63 Million $1.10 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.